Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
5(29%)
Results Posted
57%(4 trials)
Terminated
2(12%)

Phase Distribution

Ph early_phase_1
2
12%
Ph not_applicable
4
24%
Ph phase_2
5
29%
Ph phase_1
6
35%

Phase Distribution

8

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution17 total trials
Early Phase 1First-in-human
2(11.8%)
Phase 1Safety & dosage
6(35.3%)
Phase 2Efficacy & side effects
5(29.4%)
N/ANon-phased studies
4(23.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

5

trials recruiting

Total Trials

17

all time

Status Distribution
Active(7)
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Recruiting4
Not yet recruiting2
Terminated2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
5
Success Rate
77.8%
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (11.8%)
Phase 16 (35.3%)
Phase 25 (29.4%)
N/A4 (23.5%)

Trials by Status

active_not_recruiting16%
not_yet_recruiting212%
completed741%
recruiting424%
unknown16%
terminated212%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT05664113Phase 1

Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).

Recruiting
NCT05829109Early Phase 1

Fecal Microbiota Transplant for Patients With Chronic Pouchitis

Recruiting
NCT05286294Phase 2

Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders

Active Not Recruiting
NCT06960122Not Applicable

Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy

Not Yet Recruiting
NCT06938165Not Applicable

The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host Disease

Completed
NCT06924645Not Applicable

Fecal Microbiota Transplantation for Preventing Gastrointestinal Symptoms in Extrapulmonary Neuroendocrine Neoplasms: A Real-World Study

Not Yet Recruiting
NCT04926103Not Applicable

Screening Donors, Fecal Microbiota Transplant Program in Ulcerative Colitis

Recruiting
NCT03678493Phase 2

A Study of FMT in Patients With AML Allo HSCT in Recipients

Completed
NCT05253768Phase 2

Safety and Efficacy of Human Microbiota Transplantation for Overweight and Obese Type 2 Diabetes Mellitus

Recruiting
NCT02922816Phase 1

FMT for MDRO Colonization After Infection in Renal Transplant Recipients

Terminated
NCT02330653Phase 1

Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis

Completed
NCT03078803Phase 2

Fecal Transplant for Crohn's Disease

Completed
NCT05076656Early Phase 1

Epigenetic and Microbiota Modifications

Completed
NCT02417974Phase 2

Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)

Terminated
NCT03353402Phase 1

Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy

Unknown
NCT02465463Phase 1

Early FMT for C.Difficile

Completed
NCT01704937Phase 1

Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum

Completed

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17